Saskia Vosslamber

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

Hennie G. Raterman, Saskia Vosslamber, Sander de Ridder et al. · Arthritis Research & Therapy · 2012 · 184 citations · Full text

The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

Joyce Lübbers, Mikael Brink, Lotte A van de Stadt et al. · Annals of the Rheumatic Diseases · 2013 · 157 citations

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients

Lisa G. M. van Baarsen, Saskia Vosslamber, Marianne Tijssen et al. · PLoS ONE · 2008 · 114 citations · Full text

Methotrexate Normalizes Up‐Regulated Folate Pathway Genes in Rheumatoid Arthritis

Marjolein Blits, Gerrit Jansen, Yehuda G. Assaraf et al. · Arthritis & Rheumatism · 2013 · 66 citations

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation

Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Bas D. Koster et al. · Cancer Immunology Research · 2015 · 61 citations